Vimarsana
Biggest News Aggregation in the World

Page 18 - Roche Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Group Today - Breaking & Trending Today

Novartis, Roche's Food Allergies Treatment Xolair Gets FDA Approval - Vimarsana News

Novartis, Roche's Food Allergies Treatment Xolair Gets FDA Approval

By Sabela Ojea Novartis and Roche Holding said the U.S. Food and Drug Administration approved their Xolair treatment to reduce allergic reactions following the exposure to one or more foods....

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies - Vimarsana News

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate...

Kildare Nationalist — Naas Shopping Centre to open for Punchestown Festival - Vimarsana News

Kildare Nationalist — Naas Shopping Centre to open for Punchestown Festival

THE first phase of the renovated Naas Shopping Centre will be open in time for the Punchestown Festival on 25 April according to the developer. The Forge Pub is…

Roche enters into collaboration agreement with PathAI to expand digital pathology capabilities for companion diagnostics - Vimarsana News

Roche enters into collaboration agreement with PathAI to expand digital pathology capabilities for companion diagnostics

PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion...

Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury - Vimarsana News

Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury

The DOSED Clinical Study Will Evaluate a Novel Delivery Device in Subacute and Chronic Spinal Cord Injury Patients ...